Ultragenyx Pharmaceutical, Inc. (RARE)
15.22
+0.47
(+3.19%)
USD |
NASDAQ |
Oct 02, 16:00
15.33
+0.11
(+0.72%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Market Cap : 1.496B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.496B |
| October 01, 2026 | 1.450B |
| September 30, 2026 | 1.477B |
| September 29, 2026 | 1.506B |
| September 28, 2026 | 1.417B |
| September 25, 2026 | 1.425B |
| September 24, 2026 | 1.452B |
| September 23, 2026 | 1.463B |
| September 22, 2026 | 1.535B |
| September 21, 2026 | 1.440B |
| September 18, 2026 | 1.426B |
| September 17, 2026 | 1.425B |
| September 16, 2026 | 1.266B |
| September 15, 2026 | 1.285B |
| September 14, 2026 | 1.338B |
| September 11, 2026 | 1.406B |
| September 10, 2026 | 1.416B |
| September 09, 2026 | 1.407B |
| September 08, 2026 | 1.463B |
| September 04, 2026 | 1.504B |
| September 03, 2026 | 1.460B |
| September 02, 2026 | 2.608B |
| September 01, 2026 | 2.537B |
| August 31, 2026 | 2.478B |
| August 28, 2026 | 2.517B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.581B |
| August 26, 2026 | 2.599B |
| August 25, 2026 | 2.601B |
| August 24, 2026 | 2.528B |
| August 21, 2026 | 2.539B |
| August 20, 2026 | 2.489B |
| August 19, 2026 | 2.579B |
| August 18, 2026 | 2.506B |
| August 17, 2026 | 2.569B |
| August 14, 2026 | 2.604B |
| August 13, 2026 | 2.593B |
| August 12, 2026 | 2.640B |
| August 11, 2026 | 2.650B |
| August 10, 2026 | 2.634B |
| August 07, 2026 | 2.547B |
| August 06, 2026 | 2.538B |
| August 05, 2026 | 2.451B |
| August 04, 2026 | 2.537B |
| August 03, 2026 | 2.459B |
| July 31, 2026 | 2.441B |
| July 30, 2026 | 2.552B |
| July 29, 2026 | 2.45B |
| July 28, 2026 | 2.546B |
| July 27, 2026 | 2.635B |
| July 24, 2026 | 2.636B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 464.42B |
| Biogen, Inc. | 32.48B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Ionis Pharmaceuticals, Inc. | 7.212B |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
Market Cap Related Metrics
| PS Ratio | 2.134 |
| PEG Ratio | -0.4607 |
| Price | 15.22 |
| Earnings Yield | -38.38% |
| PEGY Ratio | -0.4607 |